Bank of New York Mellon’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Bank of New York Mellon’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-22,020	Closed	-$3.08K	–	4316
2024 Q1	$3.08K	Hold	22,020	–	–	﹤0.01%	4144
2023 Q4	$3.2K	Hold	22,020	–	–	﹤0.01%	4297
2023 Q3	$3.86K	Hold	22,020	–	–	﹤0.01%	4332
2023 Q2	$68.7K	Buy	+22,020	New	+$65.5K	﹤0.01%	4129
2021 Q2	–	Sell	-32,303	Closed	-$285K	–	4491
2021 Q1	$285K	Sell	32,303 -1,970	-6%	-$21.6K	﹤0.01%	3928
2020 Q4	$351K	Buy	34,273 +10,142	+42%	+$111K	﹤0.01%	3765
2020 Q3	$218K	Hold	24,131	–	–	﹤0.01%	3818
2020 Q2	$172K	Buy	24,131 +12,535	+108%	+$133K	﹤0.01%	3834
2020 Q1	$111K	Buy	+11,596	New	+$149K	﹤0.01%	3844

Other funds holding GRTX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Bank of New York Mellon's GRTX Position: Q2 2024 in Review

Bank of New York Mellon sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 22,020 shares — an estimated $3.08K sold.

Bank of New York Mellon first reported a position in GRTX in Q1 2020 and held it in 9 quarters. The position peaked at $351K in Q4 2020. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

Bank of New York Mellon reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Bank of New York Mellon sold 22,020 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $3.08K.
Bank of New York Mellon first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2020 and held it in 9 quarters.
Bank of New York Mellon's Galera Therapeutics, Inc. Common Stock position peaked at $351K in Q4 2020.
1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.